University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...

In this video, David A. Eichenbaum, MD, FASRS, discusses late-stage wet age-related macular degeneration assets presented at the American Academy of Ophthalmology meeting.Eichenbaum noted that ...

Menlo Park resident Carmen Caricchio is on a quest to cure childhood inherited retinal diseases, a group of rare conditions that cause the degeneration of the retina and can lead to vision impairment ...

No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show no safety ...

The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...

Background: This study investigated novel magnetic resonance imaging (MRI) techniques, including intravoxel incoherent motion (IVIM) and fat analysis & calculation technique (FACT) to detect early ...

A new study in The New England Journal of Medicine revealed that the PRIMA brain computer interface (BCI) retinal implant helped people with advanced age-related macular degeneration regain some ...

Preliminary studies suggest GLP-1s may offer long-term vision protection for people without diabetes, but researchers caution more research is still needed. During a 10-year study, people without ...

Age-related macular degeneration (AMD) is a leading cause of blindness in the older population. Geographic atrophy is an advanced stage of dry AMD, characterized by irreversible vision loss due to the ...